[1]
“Current Global Perspectives on the Pharmacotherapy of Helicobacter Pylori Infection: Therapeutic Implications for Sub-saharan Africa”, mjz, vol. 46, no. 3, pp. 228–237, Jan. 2020, doi: 10.55320/mjz.46.3.226.